GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Valeo Pharma Inc (OTCPK:VPHIF) » Definitions » Current Accrued Expense

Valeo Pharma (Valeo Pharma) Current Accrued Expense : $1.66 Mil (As of Jan. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Valeo Pharma Current Accrued Expense?

Valeo Pharma's Current Accrued Expense for the quarter that ended in Jan. 2024 was $1.66 Mil.

Valeo Pharma's quarterly Current Accrued Expense increased from Jul. 2023 ($1.41 Mil) to Oct. 2023 ($1.66 Mil) but then declined from Oct. 2023 ($1.66 Mil) to Jan. 2024 ($1.66 Mil).

Valeo Pharma's annual Current Accrued Expense increased from Oct. 2021 ($0.21 Mil) to Oct. 2022 ($1.02 Mil) and increased from Oct. 2022 ($1.02 Mil) to Oct. 2023 ($1.66 Mil).


Valeo Pharma Current Accrued Expense Historical Data

The historical data trend for Valeo Pharma's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Valeo Pharma Current Accrued Expense Chart

Valeo Pharma Annual Data
Trend Oct17 Oct18 Oct19 Oct20 Oct21 Oct22 Oct23
Current Accrued Expense
Get a 7-Day Free Trial - 0.08 0.21 1.02 1.66

Valeo Pharma Quarterly Data
Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24
Current Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.13 1.14 1.41 1.66 1.66

Valeo Pharma Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.


Valeo Pharma Current Accrued Expense Related Terms

Thank you for viewing the detailed overview of Valeo Pharma's Current Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Valeo Pharma (Valeo Pharma) Business Description

Traded in Other Exchanges
Address
16667, Hymus Boulevard, Kirkland, QC, CAN, H9H 4R9
Valeo Pharma Inc is a Canadian specialty pharmaceutical company focused on acquiring either through acquisitions, in-licensing, or similar arrangements. The company operates in two divisions: Branded prescription products and Niche hospital injectable products. Its product portfolio includes medicines for Respiratory/Allergy, Ophthalmology, Neurology, and Oncology.